RxDoctor Payments Data

Marie Hebert, MD

Family Medicine · Roseburg, ORNPI 1033533278

Payments from drug & device makers

$365in general payments, 2019–2025

Across 16 payments — averaging $22.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gen-probe Sales & Service, Inc.$74
  • Pfizer$58
  • GSK$44
  • Novo Nordisk$32
  • AbbVie$30
  • Otsuka America Pharmaceutical, Inc.$24
  • plus $103 from 6 others

What the payments were for

  • Food & beverage$365100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gen-probe Sales & Service, Inc.1$74
Pfizer3$58
GSK2$44
Novo Nordisk2$32
AbbVie1$30
Otsuka America Pharmaceutical, Inc.1$24
Amgen1$19
Exact Sciences1$19
Ultragenyx Pharmaceutical Inc.1$17
Merck1$17
AstraZeneca1$16
Lilly USA, LLC1$15

How this compares

$365 in reported general payments places this provider in the 75th percentile of 1,221 family medicine providers in Oregon.

See all family medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$1,818
Medicare patients
15
Services billed
21

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban19$18,081
Nebivolol Hcl18$1,094
Gabapentin46$977
Levothyroxine Sodium95$886
Pantoprazole Sodium42$608
Albuterol Sulfate HfaAlbuterol Sulfate24$568
Pravastatin Sodium42$529
Metoprolol Succinate27$508
Montelukast Sodium40$453
Atorvastatin Calcium46$416
Amlodipine Besylate66$404
Lisinopril45$399
Losartan Potassium61$365
Omeprazole43$360
Potassium Chloride14$345

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$58$18,08119 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,221 family medicine providers in Oregon.

Other family medicine in Roseburg

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →